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ABSTRACT
Introduction Descendants of patients with dementia 
have a higher risk to develop dementia. This study aims to 
investigate the uptake and effectiveness of an online tailor- 
made lifestyle programme for dementia risk reduction 
(DRR) among middle- aged descendants of people with 
recently diagnosed late- onset dementia.
Methods and analysis Demin is a cluster randomised 
controlled trial, aiming to include 21 memory clinics of 
which 13 will be randomly allocated to the passive (poster 
and flyer in a waiting room) and 8 to the active recruitment 
strategy (additional personal invitation by members of 
the team of the memory clinic). We aim to recruit 378 
participants (40–60 years) with a parent who is recently 
diagnosed with Alzheimer’s disease or vascular dementia 
at one of the participating memory clinics. All participants 
receive a dementia risk assessment (online questionnaire, 
physical examination and blood sample) and subsequently 
an online tailor- made lifestyle advice regarding protective 
(Mediterranean diet, low/moderate alcohol consumption 
and high cognitive activity) and risk factors (physical 
inactivity, smoking, loneliness, cardiovascular diseases 
(CVD), hypertension, high cholesterol, diabetes, obesity, 
renal dysfunction and depression) for dementia. The primary 
outcome is the difference in uptake between the two 
recruitment strategies. Secondary outcomes are change(s) 
in (1) the Lifestyle for Brain Health score, (2) individual health 
behaviours, (3) health beliefs and attitudes towards DRR and 
(4) compliance to the tailor- made lifestyle advice. Outcomes 
will be measured at 3, 6, 9 and 12 months after baseline. The 
effectiveness of this online tailor- made lifestyle programme 
will be evaluated by comparing Demin participants to a 
matched control group (lifelines cohort).
Ethics and dissemination This study has been approved 
by the Dutch Ministry of Health, Welfare and Sport 
according to the Population Screening Act. All participants 
have to give online informed consent using SMS- tan 
(transaction authentication number delivered via text 
message). Findings will be disseminated through peer- 
reviewed journals and (inter)national conferences.
Trial registration number NTR7434.
Strengths and limitations of this study
 ► This is the first multicentre trial that focuses on de-
mentia risk reduction in middle- aged descendants 
of recently diagnosed patients with Alzheimer’s dis-
ease or vascular dementia.
 ► The programme gives participants insight in their 
risk and protective factors for dementia and provides 
a tailor- made online lifestyle advice with regard to 
13 modifiable risk factors for dementia, taking the 
stages of (health behaviour) change into account.
 ► The application ensures the privacy of the participants 
by using SMS- tan for logging in their personal account 
and signing the electronic informed consent form.
 ► The web- based application (demin.nl) functions fully 
automatically, making it easy to implement the study 
in other memory clinics and settings.
 ► Changing health behaviour is difficult and it is un-
clear whether a tailor- made online lifestyle advice is 
sufficient to change health behaviour and to main-
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INTRODUCTION
Dementia is considered as a major public health 
concern.1 Due to the ageing population, the number 
of dementia cases will increase substantially in the next 
decades. In 2015, more than 46 million people worldwide 
were affected by dementia and this number is expected to 
increase to 131 million by 2050.2 This rise in people with 
dementia carries a high economic and social burden for 
society.1 In 2015, global costs of dementia reached 818 
billion US dollars and will increase further.3 Currently, no 
curative treatments are available. Therefore, prevention 
is a key element to counteract the dementia epidemic.4 5
The most common types of dementia are Alzheimer’s 
disease (AD) (60%–70%), vascular dementia (VD) 
(15%–20%) or a combination of AD and VD (mixed 
dementia).6–8 The presence of a first- degree relative with 
AD doubles the risk for developing AD.9 This increased 
risk has several reasons. First, descendants of people 
with AD more often have a higher genetic predisposition 
for AD (eg, carrier of the apolipoprotein E (APOE) ε4 
allele).9 Second, high blood pressure, vascular diseases 
and other vascular risk factors (ie, diabetes type 2, obesity, 
hypercholesterolemia) often cluster in families.10 Lastly, 
psychosocial behaviour runs in the family and also affects 
health behaviour and lifestyle.11 12 Not surprisingly, indi-
viduals with a parent who is recently diagnosed with AD 
or VD often worry about their own risk of developing 
dementia. Therefore, this life event (parental diagnosis 
of dementia) might encourage the willingness of individ-
uals to change their health behaviour.13
Parental family history has been associated with an 
increased risk of dementia independently of known 
genetic risk factors.9 14 Therefore, a healthy lifestyle might 
be beneficial for individuals with a positive family history, 
especially for APOE ε4 carriers.15–18 Over the last decade, 
evidence of modifiable risk factors for dementia has been 
mounting.4 6 19 The Lancet commission on dementia 
prevention, intervention and care demonstrated that 
35% of the dementia cases is attributable to modifiable 
risk factors (ie, less education, hearing loss, midlife 
hypertension, midlife obesity, smoking, depression, phys-
ical inactivity, social isolation and diabetes) and recom-
mended to start interventions including more childhood 
education, promotion of physical exercise, reduction of 
smoking, maintaining social engagement and manage-
ment of hypertension, diabetes, obesity, depression and 
hearing loss.4 6 20 Other major risk factors are hyperlipi-
daemia, coronary heart disease, renal dysfunction, Medi-
terranean diet and cognitive activity.19
Only a few studies examined the effectiveness of 
targeting these modifiable factors on cognitive decline 
and dementia incidence through a multidomain interven-
tion, such as the Finnish Geriatric Intervention Study to 
Prevent Cognitive Impairment and Disability (FINGER) 
study,21 the Prevention of Dementia by Intensive Vascular 
care (PreDIVA) study22 and the The Multi- domain 
Alzheimer Preventive Trial (MAPT) study.23 These studies, 
with a follow- up varying from 2 to 6 years, found small or 
non- significant effects on cognition in older participants 
(eg, >60 years).21–23 Starting multidomain interventions 
earlier in life might be promising as cognitive decline 
begins already in midlife.24 25 However, since dementia is 
mainly prevalent in the elderly, a long follow- up period 
of approximately 20 years would be required in order to 
determine the effectiveness of interventions on dementia 
incidence.24–26 Furthermore, tailoring interventions 
improves the effectiveness of health behaviour change 
interventions.27 Web- based interventions have the poten-
tial to support health behaviour change as there is the 
opportunity to tailor lifestyle advice.28–31 They were espe-
cially effective when a theoretical basis or conceptual 
framework (eg, health belief model (HBM), transtheoret-
ical model, theory of planned behaviour, I(integrated)- 
change model32–36), behaviour change techniques (eg, 
providing feedback on performance and information on 
the consequences of unhealthy behaviour) and several 
modes of delivery had been used.27
The first challenge of health behaviour change 
interventions is to achieve a high level of uptake for 
screening (eg, assessing risk and protective factors for 
dementia), reflecting the willingness to participate. A 
systematic review identified a large variation in uptake in 
health checks and lifestyle intervention programmes,37 
depending on the type of recruitment strategy. The two 
main types of strategies for recruitment are the active and 
passive recruitment strategy. Active recruitment involves 
a personal invitation by the project staff and healthcare 
providers (eg, proactive) and passive recruitment involves 
recruitment of participants through various channels 
such as flyers and advertisements (eg, reactive).38 The 
most effective recruitment strategy is a proactive referral 
from a healthcare provider, while displaying posters and 
flyers showed to be less effective.39 40 Uptake also depends 
on other factors as described in social cognition models 
(eg, knowledge, perceived susceptibility and severity, 
facilitators, benefits and barriers and attitude towards 
such interventions).32–36 These factors are essential and 
useful to make a well- informed decision about dementia 
risk assessment, considering the possible benefits and 
harms. Therefore, information on dementia, the risk 
and protective factors for dementia, heritability and 
how to tackle risk and protective factors for dementia 
are important factors in the development of a web- based 
intervention. A previous study showed that the majority of 
the Dutch general population is unaware of the relation-
ship between modifiable risk factors and brain health, 
particularly regarding major cardiovascular risk factors 
(eg, hypertension, hypercholesterolemia and coronary 
heart disease).41 It is shown that this lack of knowledge 
is a barrier to the uptake and maintenance of healthy 
behaviours for middle- aged individuals.42 Having a parent 
who is recently diagnosed with AD or VD could have led 
to an increased knowledge on dementia and risk percep-
tion.13 Therefore, middle- aged descendants of recently 
diagnosed people with AD or VD might be receptive to 
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as they just realised their (familial) risk.13 43 Although we 
expect that the uptake in the active recruitment strategy 
will be higher compared with the passive recruitment 
strategy, participants recruited via the passive recruitment 
strategy might be more intrinsically motivated to adopt 
and maintain their healthy lifestyle and less likely to drop 
out of the study.
To our knowledge, none of the health behaviour inter-
vention studies were aimed at a specific group of middle- 
aged adults with increased risk for dementia due to their 
parental family history of dementia. Therefore, this study 
aims to investigate the uptake and effectiveness of a tailor- 
made online lifestyle programme for dementia risk reduc-
tion (DRR) among middle- aged descendants of recently 
diagnosed (in the last 6 months) people with AD or VD 
in the Netherlands. This will give insight into what extent 
it is feasible to recruit middle- aged descendants of people 
with AD or VD at the memory clinics and whether these 
potential participants are willing to participate in a tailor- 
made online lifestyle programme in order to reduce their 
dementia risk.
METHODS AND ANALYSIS
Study setting and design
This study is a pragmatic cluster randomised controlled 
trial (RCT), including 21 participating memory clinics in 
the Netherlands who are randomly allocated to a passive 
or active recruitment of participants. Memory clinics allo-
cated to the active recruitment strategy invite potential 
participants face- to- face by a member of the team of the 
memory clinic to participate in the tailor- made online life-
style programme for DRR (also called the Demin study), 
next to posters and flyers that are placed in the waiting 
room of the memory clinic. Memory clinics allocated to 
the passive recruitment strategy, do not invite potential 
participants proactively, but invite potential participants 
to participate in the Demin study by posters and flyers 
that are placed in the waiting room of the memory clinic.
Patients with AD or VD (or their caregivers) receive an 
envelope either at the registration desk of the memory 
clinic or after the consult of the patient (only with active 
recruitment). This envelope is addressed to the middle- 
aged descendants of patients with recently diagnosed 
AD or VD and includes a patient information form 
(PIF) with information about the content of the study, 
the advantages and disadvantages of study participation 
and how potential participants can participate. Potential 
participants (one family member per patient) are asked 
to register themselves (eg, making an account) on the 
Demin website ( www. demin. nl), by using the memory 
clinic specific login access code, which is reported on 
the front page of the PIF and represents the memory 
clinic in which the parent was diagnosed. The decision to 
participate is confirmed by the participants by signing the 
online informed consent form (electronic signature by 
using SMS- tan). After signing this form, individuals from 
both recruitment strategies are able to log in to their 
personalised website ‘My Demin’ and continue the inter-
vention in an equal manner. The personalised website ‘My 
Demin’ is secured and only accessible for the participant 
by logging in with their personal email address, password 
and SMS- tan code. ‘My Demin’ contains the following 
information: (1) My personal (account) information, (2) 
Message inbox, (3) My online questionnaires, and (4) My 
personal health profile including online tailor- made life-
style advice. After participants have completed the online 
questionnaire, they automatically receive a message with 
a request to make an appointment for physical examina-
tion including a fasting blood sample. Moreover, partici-
pants can invite siblings to participate in the study in ‘My 
Demin’.
The functionalities provided by the Demin website are 
based on the literature and input we received from people 
with a parent with dementia (focus group discussions).
Randomisation of memory clinics
To prevent contamination between the two recruitment 
strategies, randomisation is performed at the level of 
the memory clinics. To enhance comparability between 
the intervention (participants of the active recruitment 
strategy) and control group (participants of the passive 
recruitment strategy), the memory clinics will be matched 
and randomised by a statistician, who is blind to the iden-
tity of the memory clinics and not involved in the study. 
First, all participating memory clinics will be matched 
into pairs based on the following criteria: (1) number of 
newly diagnosed dementia (VD, AD or mixed dementia) 
patients seen per year (range vary from 60 to 350 patients 
per year) and (2) the average social economic position 
(SEP) of the population living around the memory clinic 
(neighbourhood SEP), based on data from Statistics 
Netherlands.44 Second, the matched memory clinics will 
be randomised (pairwise randomisation) to an active 
recruitment strategy or passive recruitment strategy using 
a computer- generated random number list. As we expect 
a higher response rate in the active recruitment strategy 
group, we use an active:passive recruitment strategy ratio 
of 8:13 (see sample size calculations).
Study population
Eligible participants are middle- aged individuals (40–60 
years old) with a parent who is recently (less than 6 
months ago) diagnosed with AD or VD (or mixed 
dementia) at one of the participating memory clinics in 
the Netherlands (see Acknowledgements section). Indi-
viduals should provide informed consent, be able to fill 
out an online Dutch questionnaire. Pregnant women are 
excluded from participation.
Sample size calculations
The primary outcome measure is uptake, which is defined 
as the percentage of eligible individuals that signed the 
online informed consent form and completed baseline 
assessment (online questionnaire and physical exam-
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a difference of 20% in uptake between the passive and 
active recruitment strategy (30% vs 50%), we need 94 
participants in each group to achieve a power of 80% 
with alpha levels of 0.05 (total=188 participants). To take 
cluster randomisation into account, we use the formula 
1+((n−1)*ICC) (inflation factor), where n is the average 
number of included participants per memory clinic and 
ICC is Intra Class Correlation.45 The ICC is unknown, 
but an ICC of 0.05 is a common value for cluster RCTs 
in hospitals.46 The estimated average of included partici-
pants per memory clinic per year is n=15 using a passive 
recruitment strategy and n=25 using an active recruitment 
strategy, taking into account non- response. With unequal 
cluster sizes, ‘n’ is replaced by ‘m’, where m is the sum 
of (M)2/sum(M) ((152+252)/(15+25)).47 This results in a 
sample size inflation factor of (1+((21.25–1)*0.05)=2.01. 
Therefore, the total number of participants needed is 
378 (2.01*188). In order to recruit 378 participants, we 
need 21 memory clinics, of which eight memory clinics 
(responsible for 189 included participants) will be allo-
cated to the active recruitment strategy and 13 memory 
clinics (responsible for 189 included participants) will be 
allocated to the passive recruitment strategy.
Demin website
The Demin website is available for everyone and provides 
information about dementia, heredity of dementia, risk 
and protective factors for dementia, and how to tackle 
potential risk factors for dementia. The health informa-
tion will be provided by written text and in an audiovisual 
format, such as a spoken animation, to assure inclusion 
of participants with different levels of health literacy.48 
According to the cognitive theory of multimedia learning, 
people process visual and auditory information through 
different channels.49 50 It is known that health informa-
tion provided by various channels, such as written text 
and spoken animations, improves information processing 
compared with information only provided through written 
text or spoken animations.49 50 The instructions for regis-
tration (making an account, signing informed consent) 
are also provided as written text and visual screenshots 
representing the steps of the registration process.
Online tailor-made lifestyle programme for dementia risk 
reduction
After participants give online informed consent, partic-
ipants have access to the online tailor- made lifestyle 
programme for DRR, which consists of (1) a dementia 
risk assessment and (2) an online tailor- made lifestyle 
advice including a personal health profile targeting risk 
and protective factors for dementia.
Dementia risk assessment
The dementia risk assessment consists of filling out an 
online questionnaire (in ‘My Demin’) and physical exam-
ination, including a fasting blood sample, at one of the 
21 participating memory clinics in order to determine 
whether risk and protective factors are present. In order 
to minimise the amount of missing data, validation and 
skip- and- fail rules were implemented in the online ques-
tionnaire. Furthermore, automatic reminders are sent to 
the participant if the online questionnaire was not filled 
in within 2 weeks. Physical examination will be conducted 
by the team of the local memory clinic and includes the 
following measurements: height (in cm) (SECA 222 stadi-
ometer), body weight (in kg) without shoes (SECA 761 
scale), waist and hip circumference (in cm) (SECA 200 
measuring tape) and three measurements of diastolic and 
systolic blood pressure (in mm Hg) (Welch Allyn ‘Spot 
Vital Signs’51). After physical examination, which takes 
approximately 15 min, a fasting blood sample (maximum 
of 21 mL) is taken for direct laboratory measurement of 
glucose, HbA1C, total cholesterol, high- density lipopro-
tein, low- density lipoprotein, triglycerides and serum 
creatinine. The results of the physical examination 
(height, body weight, blood pressure and waist and hip 
circumference) are sent to the researcher (JV) to check 
the entry of the results by the participants. The results 
of the direct laboratory measurements are sent to the 
medical doctor (EMA) of the University Medical Centre 
Groningen to check for deviating values.
Risk and protective factors for dementia
Through the online questionnaire and physical examina-
tion, data on 13 currently known protective (ie, Mediterra-
nean diet, low/moderate alcohol consumption, cognitive 
activity) and risk factors (ie, physical inactivity, smoking, 
loneliness, cardiovascular diseases, hypertension, high 
cholesterol, diabetes mellitus, obesity, renal dysfunction, 
depression) for dementia are collected.6 19 52 See table 1 
for an overview of the assessment measures. The measure-
ments of these risk and protective factors are described in 
online supplemental file 1.
Personal health profile
After completion of the baseline dementia risk assess-
ment (including the data entry of the physical examina-
tion and laboratory measurements), a personal health 
profile is automatically provided in the personal account 
of the participants (My Demin). The personal health 
profile gives an overview of the presence of the risk and 
protective factors for dementia, without including the 
weight of the risk and protective factors. According to 
the Lifestyle for Brain Health (LIBRA) score, each risk 
and protective factor19 52 53 is categorised into one of the 
following categories: (1) room for improvement, (2) 
remember to manage well, (3) keep this up (see table 2). 
The ‘keep this up’ category represents factors that partic-
ipants are currently managing well or diseases they do not 
have. The ‘room for improvement’ category represents 
the factors that could be improved by health behaviour 
change (eg, quit smoking, become more physical active, 
change diet, drink less alcohol). The category ‘remember 
to manage well’ is assigned when a risk factor (ie, 
cardiovascular diseases, hypertension, high cholesterol, 
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present, but the disease is managed well as participants 
have regular meetings with their general practitioner for 
disease control (diabetes mellitus) or use medication for 
disease management (cardiovascular diseases, hyperten-
sion, high cholesterol, renal dysfunction and depression) 
(see figure 1).
Tailor-made online lifestyle advice for dementia risk reduction
Participants also receive an online tailor- made lifestyle 
advice targeting risk factors associated with dementia and 
following the Dutch guidelines for a healthy diet, alcohol 
consumption, physical activity, diabetes mellitus, renal 
dysfunction and cardiovascular health including choles-
terol levels and BMI.54–58 For each risk and protective 
factor, information is given about (1) the norm (cut- off 
point for not having this risk factor), (2) the associa-
tion between the risk factor and dementia and (3) life-
style advice how to tackle this factor. The online lifestyle 
advice was tailored to the participants based on (1) the 
presence of risk factors, (2) the strength of the associa-
tion between the risk factors and dementia19 52 and (3) 
the stages of change of the health behaviour- related risk 
factors (physical inactivity, diet, alcohol consumption, 
smoking behaviour, cognitive activity, social activity). The 
stages of change are determined by asking ‘Which state-
ment fits best for you?’, where each answer option reflects 
one of the following stages of change: pre- contemplation, 
contemplation, preparation, action and maintenance.33 
It is known that participants who are in the preparation 
and action stage are more willing to change their health 
behaviour, therefore lifestyle advice for these factors are 
given first.33
In case medically relevant findings are found, including 
untreated diabetes mellitus (glucose ≥7.0 mmol/L or 
(glucose ≥6.1 mmol/L and HbA1C>53 mmol/mol)), 
untreated renal dysfunction (estimated glomerular filtra-
tion rate (eGFR) ≤60 mL/min/1.73 m2) and increased 
risk for developing CVD (CVD risk ≥10% according to 
the Dutch Systematic Coronary Risk Evaluation (SCORE) 
formula59), participants receive, in addition to the online 
tailor- made lifestyle advice, a separate message in their 
personal inbox with the recommendation to contact 
their general practitioner to verify the results and discuss 
whether treatment is needed.
Outcome measures and measurements
Participants are invited to fill in the online questionnaire 
at baseline and four times (3, 6, 9 and 12 months after 
baseline measurement) during 1 year follow- up. Phys-
ical examination, including the fasting blood sample for 
direct laboratory measurements, is only done at baseline 
and 12 months after baseline measurement (see online 
supplemental file 2). Data from the online questionnaires 
and physical examination are stored automatically in an 
electronic case report form (eCRF) data management 
programme, which is only accessible by the researchers 
involved in this study. Data from the direct laboratory 
measurement are entered manually in the eCRF data 
management programme. Every month, memory clinics 
are requested to provide information about (1) the 
number of eligible participants (eg, new cases of AD and 
VD), (2) the number of envelopes that are given away and 
(3) any difficulties with the recruitment of participants. 
In order to keep participating memory clinics involved 
Table 1 Assessment measures at baseline and follow- up
Baseline 3 months 6 months 9 months 12 months
Risk and protective factors         
Smoking Q Q Q Q Q
Physical inactivity (SQUASH, IPAQ) Q Q Q Q Q
Mediterranean diet (FFQ) Q Q Q Q Q
Alcohol consumption (FFQ) Q Q Q Q Q
High cognitive activity (CRIq) Q Q Q Q Q
Loneliness (de Jong Gierveld, 6- item) Q Q Q Q Q
Cardiovascular diseases Q Q Q Q Q
Obesity (body weight, height) Q+PE Q Q Q Q+PE
Hypertension (SBP, DBP) Q+PE Q Q Q Q+PE
High cholesterol (LDL, HDL, TC) Q+FBS Q Q Q Q+FBS
Diabetes mellitus (glucose, HbA1C) Q+FBS Q Q Q Q+FBS
Renal dysfunction (eGFR) Q+FBS Q Q Q Q+FBS
Depression (CES- D) Q Q Q Q Q
CES- D, centre for epidemiological studies depression scale; CRIq, cognitive reserve index questionnaire (adapted); DBP, diastolic blood 
pressure; eGFR, estimated glomerular filtration rate; FBS, fasting blood sample; FFQ, food frequency questionnaire; HbA1C, haemoglobin 
A1C; HDL, high- density lipoproteins; IPAQ, international physical activity questionnaire; LDL, low- density lipoproteins; PE, physical 
examination; Q, online questionnaire; SBP, systolic blood pressure; SQUASH, short questionnaire to assess health- enhancing physical 
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in the study, every 3 months newsletters are sent around 
and memory clinics are contacted monthly to evaluate 
the uptake.
Primary outcome
The primary outcome is the difference in uptake (eg, 
the percentage of eligible people that signed the online 
informed consent form and completed a risk assess-
ment of the total number of eligible people) between 
the active and passive recruitment strategy. The total 
number of eligible people in each recruitment group 
(active vs passive) are based on the number of new cases 
of AD or VD in all memory clinics during the recruitment 
period, assuming an average of one child per patient with 
dementia receiving the envelope with the PIF including 
a login access number. Due to privacy regulations, it is 




(1) The change in LIBRA score. The LIBRA score has 
been validated among individuals in midlife and reflects 
an individual’s potential to reduce their risk on devel-
oping late- onset dementia.52 The LIBRA score consists of 
12 currently known protective (ie, Mediterranean diet, 
low/moderate alcohol consumption, cognitive activity) 
and risk factors (ie, physical inactivity, smoking, CVD, 
hypertension, high cholesterol, diabetes mellitus, obesity, 
renal dysfunction, depression) for dementia and ranges 
from −5.9 (low risk for developing dementia) to 12.7 
(high risk for developing dementia).
Table 2 Definition for the three categories in the personal health profile at baseline
Modifiable risk factors Keep this up Remember to manage well Room for improvement
Diet MIND- diet score=14 points NA MIND- diet score<14 points
Alcohol consumption Average number of units of 
alcohol per week≤7 and number 
of units per day is: ≤3 for women 
or ≤4 for men
NA Average number of units of 
alcohol per week>7 or number of 
units per day is: >3 for women or 
>4 for men
Cognitive activity Paid working hours≥24 or
CRIq score≥50
NA Paid working hours<24 and CRIq 
score<50
Physical activity (MVPA/week≥150 and
sitting time≤8 hours/day) or
(MVPA/week<150 and sitting 
time<4 hours/day)
NA Sitting time>8 hours/day or 
(sitting time≥4 hours/day and 
MVPA/week<150)
Smoking Past or never smoker NA Current smoker
Loneliness De Jong Gierveld score<2 NA De Jong Gierveld score≥2
CVD No CVD At least one CVD and receives 
medical treatment
At least one CVD and no medical 
treatment
Weight BMI≥18.5 and BMI<25.0 NA BMI<18.5 or BMI≥25.0
Blood pressure DBP<90 mmHg and SBP<140 
mmHg and no medical treatment
DBP<90 mmHg and SBP<140 
mmHg and medical treatment
DBP≥90 mmHg or
SBP≥140 mmHg
Cholesterol LDL≤2.5 mmol/L and TC/
HDL≤5 mmol/L and no medical 
treatment
LDL≤2.5 mmol/L and TC/
HDL≤5 mmol/L and medical 
treatment
LDL>2.5 mmol/L or TC/HDL>5 
mmol/L
Diabetes mellitus Glucose<7.0 mmol/L and
HbA1C≤53 mmol/mol
(HbA1C≤53 mmol/mol 
and medical treatment) or 
(glucose<7.0 mmol/L and 
HbA1C>53 mmol/mol and 
medical treatment)
(HbA1C>53 mmol/mol and 
no medical treatment) or 
(glucose≥7.0 mmol/L and 
HbA1C>53 mmol/mol) or 
(glucose≥7.0 mmol/L and 
HbA1C≤53 mmol/mol and no 
medical treatment)
Kidney eGFR≥60 mL/min/1.73 m2 eGFR<60 mL/min/1.73 m2 and 
medical treatment
eGFR<60 mL/min/1.73 m2 and 
no medical treatment
Depression CES- D<16 points CES- D≥16 points and medical 
treatment
CES- D≥16 points and no medical 
treatment
BMI, body mass index; CES- D, centre for epidemiological studies depression scale; CRIq, cognitive reserve index questionnaire; CVD, 
cardiovascular diseases; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HbA1C, haemoglobin A1C; HDL, high- 
density lipoproteins; LDL, low- density lipoproteins; MIND- diet, mediterranean- DASH diet intervention for neurodegenerative delay; MVPA, 
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A one point increase in the LIBRA score is associated 
with a 19% higher risk for dementia.52 60 The definitions 
and corresponding scores for the three protective and 
ten risk factors for dementia are described in table 3.
(2) The change in the individual health behaviours, 
including physical activity (minutes of moderate to 
vigorous physical activity per week), diet (mediterranean- 
DASH diet intervention for neurodegenerative delay 
score; 0–14), alcohol consumption (number of glasses of 
alcohol per week), smoking behaviour (current smoker 
(yes/no) and number of cigarettes/cigars a day), cogni-
tive activity (leisure- time cognitive activity score and 
number of hours paid work), loneliness (overall loneli-
ness score; 0–6) and social activity (number of contacts 
per 2 weeks) and their stage of change over time. The 
stages of change are categorised into pre- contemplation 
Figure 1 An example of a personal health profile.
Table 3 Definition of risk and protective factors for dementia in the LIBRA score and corresponding scores
Modifiable risk factors Definition Score
Protective factors   
1   High cognitive activity Score ≥50 points on the Cognitive Reserve Index questionnaire (leisure time 
activities) or hours of paid work ≥24 hours
−3.2
2   Mediterranean diet MIND- diet score (0–14) =14 points −1.7
3   Low/moderate alcohol 
consumption
Average number of glasses of alcohol a week ≤7 and number of glasses a day is:
≤3 glasses for women (no binge drinking),
≤4 glasses for men (no binge drinking)
−1.0
Risk factors
4   Cardiovascular diseases Presence of at least one of the follow diseases: history of angina pectoris, 
myocardial infarction, transient ischaemic attacks, stroke or peripheral arterial 
diseases
+1.0
5   Physical inactivity Not fulfilling Dutch Norm for Physical activity defined as ≥150 min/week 
physical activity of moderate to vigorous intensity, measured with the SQUASH 
questionnaire
+1.1
6   Renal dysfunction Estimated glomerular filtration rate ≤60 mL/min/1.73 m2 +1.1
7   Diabetes mellitus Glucose (capillary blood) >7.0 mmol/L or HbA1c >53 mmol/mol +1.3
8   High cholesterol LDL >2.5 mmol/L or TC/HDL >5 +1.4
9   Smoking Current smoker +1.5
10   Obesity BMI ≥30 +1.6
11   Hypertension SBP >140 mmHg or DBP >90 mmHg +1.6
12   Depression Score ≥16 points on the Centre for Epidemiologic Studies Depression scale +2.1
BMI, body mass index; DBP, diastolic blood pressure; HbA1c, haemoglobin A1C; HDL, high- density lipoproteins; LDL, low- density 
lipoproteins; LIBRA, lifestyle for brain health; MIND- diet, mediterranean- DASH diet intervention for neurodegenerative delay; SBP, systolic 
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(1), contemplation (2), preparation (3), action (4) and 
maintenance (5).33
(3) Changes in beliefs and attitudes with regard to DRR 
are measured using the Motivation to Change Lifestyle 
and Health Behaviour for DRR Scale (MCLHB- DRR 
scale).61 62 The MCLHB- DRR scale is based on the HBM,32 
which explains health- related behaviours. Seven subscales 
of the HBM were included: perceived susceptibility, 
perceived severity, perceived benefits, perceives barriers, 
cues to action, general health motivation and self- efficacy. 
Participants are asked to rate all items on a 5- point 
Likert scale, ranging from strongly disagree (score=1) to 
strongly agree (score=5). A higher score on each subscale 
reflects a higher motivation to change their lifestyle and 
health behaviour for DRR. The Dutch version of the 
MCLHB- DRR scale, consisting of 23 items, has shown to 
be valid in the Dutch general population aged between 
30 and 80 years old.63
(4) Percentage of participants that indicated in the 
questionnaire that they have followed up the tailor- 
made online lifestyle advice (‘On what risk factors did 
you receive lifestyle advice?’ and ‘Did you follow- up the 
tailor- made lifestyle advice since the last questionnaire 
(with regard to (risk factor))’?, but also the percentage 
of participants that indicated that they have followed up 
the advice to consult their General Practitioner (‘Did you 
have contact with your general practitioner after receiving 
feedback on the risk and protective factors?’).
Statistical analyses
First, descriptive characteristics will be explored. The 
difference in uptake between the two recruitment strat-
egies will be examined using multilevel logistic regres-
sion analyses in order to correct for clustering at memory 
clinic level. We will calculate the percentage with the 
corresponding 95% CI and use an alpha of 0.05 to test 
statistical significance.
The effectiveness of the online tailor- made life-
style programme for DRR will be determined by, first 
comparing the change in LIBRA score, the individual risk 
factors and the MCLHB- DRR score between the active 
and passive recruitment strategy, and second comparing 
participants of the Demin study (active and passive 
recruitment strategy) to a control group consisting of 
Lifelines participants (large population- based cohort 
study (n>167 000)) ( www. lifelines. nl)64 in outcome. Life-
lines participants (age 40–60 years) with a parent with 
dementia will be matched (using propensity scores) on 
non- modifiable risk factors (age, gender and education) 
for dementia to participants of the Demin. Subsequently, 
multilevel analyses will be performed to examine the 
change in the LIBRA score and the individual health 
behaviours over time. In addition, possible confounding 
and interaction effects will be identified and corrected 
for in the analysis (eg, health literacy). We will calculate 
relative risks with 95% CIs and use an alpha of 0.05 to test 
significance.
Adverse events
The risk classification of this intervention is considered 
negligible, since only information and health advice is 
provided. Serious adverse events as a result of the interven-
tion are not expected, thus no data safety and monitoring 
board is installed. Potential participants are informed 
about possible adverse events. For example, dementia risk 
assessment may help raising the awareness of their suscep-
tibility in order to motivate health behaviour change,32 
however, risk assessment could also have an unfavourable 
effect. Participants may become anxious about devel-
oping dementia and could experience more stress if they 
receive their health profile. Therefore, participants are 
clearly informed that the presence or absence of risk 
and protective factors is not a reassurance that they will 
develop dementia later in life. Furthermore, participants 
are informed that there is the possibility that unexpected 
medical findings can be found. In this case, participants 
receive a separate message in their personal inbox with 
the recommendation to contact their general practitioner 
to verify the results (hypertension, high cholesterol, renal 
dysfunction, diabetes) and discuss whether treatment is 
needed. Participants may consider online risk assessment 
as a privacy risk. In this study, all personal information is 
kept separately from the research data, and participants 
use a SMS- tan code to login in their personal account.
Patient and public involvement
Descendants of people with dementia were involved in 
the development of the Demin website. We assessed the 
knowledge, beliefs and attitudes towards dementia and 
dementia risk reduction among descendants of people 
with dementia (focus group discussions). The results 
of the focus group discussions were used to develop 
the Demin website in order to improve the participant 
recruitment and encourage health behaviour change 
among participants.
Ethics and dissemination
This study is approved by the Dutch Ministry of Health, 
Welfare and Sport according to the Dutch Popula-
tion Screening Act. Research which is considered to be 
Population Screening on the ground of the Population 
Screening Act, for which ministerial approval is required, 
does not have to be assessed on the basis of the Medical 
Research Involving Human Subjects Act.65 Population 
screening is defined as ‘medical research in persons 
carried out on an entire population or a category thereof 
aimed at the detection of certain types of disease or 
certain risk indicators for the benefit of the participating 
subjects’.66 This project focuses on the attenuations of risk 
factors for dementia. Since these risk factors are merely 
lifestyle factors, a positive impact beyond dementia may 
be expected. Due to a healthy lifestyle more healthy life 
years are added to people’s lives, which may ultimately 
increase the risk on dementia as age is an important risk 
factor for dementia. This research is conducted in accor-
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All participants give informed consent to participate in 
this study, by signing an electronic informed consort form 
using SMS- tan (see online supplemental file 3). Author-
ship will be allocated using the guidelines for authorship 
defined by the International Committees of Medical 
Journal Editors.68 The results of the trial will be submitted 
to an international peer- reviewed journal and presented 
at national and international conferences.
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